FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:WAC-C10orf76

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: WAC-C10orf76
FusionPDB ID: 98668
FusionGDB2.0 ID: 98668
HgeneTgene
Gene symbol

WAC

C10orf76

Gene ID

51322

79591

Gene nameWW domain containing adaptor with coiled-coilarmadillo like helical domain containing 3
SynonymsBM-016|DESSH|PRO1741|Wwp4C10orf76
Cytomap

10p12.1|10p12.1-p11.2

10q24.32

Type of geneprotein-codingprotein-coding
DescriptionWW domain-containing adapter protein with coiled-coilarmadillo-like helical domain-containing protein 3UPF0668 protein C10orf76
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000532233, ENST00000347934, 
ENST00000354911, ENST00000375646, 
ENST00000375664, ENST00000428935, 
ENST00000370033, ENST00000311122, 
ENST00000495001, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score17 X 16 X 8=21768 X 6 X 5=240
# samples 229
** MAII scorelog2(22/2176*10)=-3.30610312772568
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/240*10)=-1.41503749927884
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: WAC [Title/Abstract] AND C10orf76 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: WAC [Title/Abstract] AND C10orf76 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)WAC(28824686)-C10orf76(103699695), # samples:1
Anticipated loss of major functional domain due to fusion event.WAC-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
WAC-C10orf76 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:28824686/chr10:103699695)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across WAC (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across C10orf76 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000375664WACchr1028824686+ENST00000370033C10orf76chr10103699695-30427486091112167
ENST00000375646WACchr1028824686+ENST00000370033C10orf76chr10103699695-2751457318821167
ENST00000347934WACchr1028824686+ENST00000370033C10orf76chr10103699695-2835541171905244
ENST00000354911WACchr1028824686+ENST00000370033C10orf76chr10103699695-272943565799244
ENST00000428935WACchr1028824686+ENST00000370033C10orf76chr10103699695-265335916723235

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000375664ENST00000370033WACchr1028824686+C10orf76chr10103699695-0.0088374590.99116254
ENST00000375646ENST00000370033WACchr1028824686+C10orf76chr10103699695-0.0068487220.9931513
ENST00000347934ENST00000370033WACchr1028824686+C10orf76chr10103699695-0.0071450780.9928549
ENST00000354911ENST00000370033WACchr1028824686+C10orf76chr10103699695-0.0096926780.99030733
ENST00000428935ENST00000370033WACchr1028824686+C10orf76chr10103699695-0.0091849240.99081504

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for WAC-C10orf76

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
WACchr1028824686C10orf76chr10103699695359114KNVHTHRVRERDGVLRLSTNAGQWKE
WACchr1028824686C10orf76chr10103699695435123KNVHTHRVRERDGVLRLSTNAGQWKE
WACchr1028824686C10orf76chr1010369969545746KNVHTHRVRERDGVLRLSTNAGQWKE
WACchr1028824686C10orf76chr10103699695541123KNVHTHRVRERDGVLRLSTNAGQWKE
WACchr1028824686C10orf76chr1010369969574846KNVHTHRVRERDGVLRLSTNAGQWKE

Top

Potential FusionNeoAntigen Information of WAC-C10orf76 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WAC-C10orf76_28824686_103699695.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:24ERDGVLRL0.99980.5214917
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:01ERDGVLRL0.99950.7737917
WAC-C10orf76chr1028824686chr10103699695541HLA-B38:02ERDGVLRL0.99920.9378917
WAC-C10orf76chr1028824686chr10103699695541HLA-B48:01RERDGVLRL0.99860.5717817
WAC-C10orf76chr1028824686chr10103699695541HLA-B13:02RERDGVLRL0.99260.619817
WAC-C10orf76chr1028824686chr10103699695541HLA-B13:01RERDGVLRL0.97130.8963817
WAC-C10orf76chr1028824686chr10103699695541HLA-B47:01RERDGVLRL0.94430.5037817
WAC-C10orf76chr1028824686chr10103699695541HLA-B44:03RERDGVLRL0.90790.8914817
WAC-C10orf76chr1028824686chr10103699695541HLA-B50:02RERDGVLRL0.86370.5485817
WAC-C10orf76chr1028824686chr10103699695541HLA-B45:01RERDGVLRL0.72850.6759817
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:13RERDGVLRL0.38930.7609817
WAC-C10orf76chr1028824686chr10103699695541HLA-B41:01RERDGVLRL0.3660.8379817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:03RERDGVLRL0.11020.8439817
WAC-C10orf76chr1028824686chr10103699695541HLA-B50:01RERDGVLRL0.03530.6566817
WAC-C10orf76chr1028824686chr10103699695541HLA-B52:01RERDGVLRL0.00220.7704817
WAC-C10orf76chr1028824686chr10103699695541HLA-B27:04VRERDGVLRL0.99810.61717
WAC-C10orf76chr1028824686chr10103699695541HLA-B27:07VRERDGVLRL0.99730.5164717
WAC-C10orf76chr1028824686chr10103699695541HLA-A30:08RVRERDGVLR0.99610.6753616
WAC-C10orf76chr1028824686chr10103699695541HLA-A74:11RVRERDGVLR0.99130.5364616
WAC-C10orf76chr1028824686chr10103699695541HLA-A74:03RVRERDGVLR0.99130.5364616
WAC-C10orf76chr1028824686chr10103699695541HLA-A74:09RVRERDGVLR0.99130.5364616
WAC-C10orf76chr1028824686chr10103699695541HLA-A31:02RVRERDGVLR0.98270.5049616
WAC-C10orf76chr1028824686chr10103699695541HLA-A30:08RVRERDGVLRL0.99760.8784617
WAC-C10orf76chr1028824686chr10103699695541HLA-B48:01RVRERDGVLRL0.87530.7329617
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:01RVRERDGVLRL0.45050.5584617
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:09ERDGVLRL0.99970.6334917
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:12ERDGVLRL0.99940.7896917
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:05ERDGVLRL0.99890.754917
WAC-C10orf76chr1028824686chr10103699695541HLA-B14:03ERDGVLRL0.9490.8206917
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:06RERDGVLRL0.99890.6165817
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:03RERDGVLRL0.97770.5516817
WAC-C10orf76chr1028824686chr10103699695541HLA-B07:12RVRERDGVL0.97710.6204615
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:04RVRERDGVL0.7820.8162615
WAC-C10orf76chr1028824686chr10103699695541HLA-B73:01ERDGVLRLS0.75810.6332918
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:08RERDGVLRL0.51830.8375817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:04RERDGVLRL0.05930.9226817
WAC-C10orf76chr1028824686chr10103699695541HLA-B48:03RVRERDGVLRL0.3380.6012617
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:31ERDGVLRL0.99950.7956917
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:04RERDGVLRL0.99830.6402817
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:21RERDGVLRL0.98170.5453817
WAC-C10orf76chr1028824686chr10103699695541HLA-B44:07RERDGVLRL0.90790.8914817
WAC-C10orf76chr1028824686chr10103699695541HLA-B44:13RERDGVLRL0.90790.8914817
WAC-C10orf76chr1028824686chr10103699695541HLA-B44:26RERDGVLRL0.90790.8914817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:73RVRERDGVL0.7760.774615
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:30RVRERDGVL0.57690.7132615
WAC-C10orf76chr1028824686chr10103699695541HLA-B41:03RERDGVLRL0.51870.6566817
WAC-C10orf76chr1028824686chr10103699695541HLA-B39:02RERDGVLRL0.47930.7624817
WAC-C10orf76chr1028824686chr10103699695541HLA-B18:11RERDGVLRL0.46360.8805817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:54RERDGVLRL0.18530.8746817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:68RERDGVLRL0.14170.6087817
WAC-C10orf76chr1028824686chr10103699695541HLA-B48:02RERDGVLRL0.13540.9233817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:53RERDGVLRL0.05160.8871817
WAC-C10orf76chr1028824686chr10103699695541HLA-B15:73RERDGVLRL0.05020.8304817
WAC-C10orf76chr1028824686chr10103699695541HLA-B50:05RERDGVLRL0.03530.6566817
WAC-C10orf76chr1028824686chr10103699695541HLA-B50:04RERDGVLRL0.03530.6566817
WAC-C10orf76chr1028824686chr10103699695541HLA-B27:10VRERDGVLRL0.99790.6857717
WAC-C10orf76chr1028824686chr10103699695541HLA-B27:09VRERDGVLRL0.99650.538717
WAC-C10orf76chr1028824686chr10103699695541HLA-A30:01RVRERDGVLR0.99620.8109616
WAC-C10orf76chr1028824686chr10103699695541HLA-B27:06VRERDGVLRL0.99620.6236717
WAC-C10orf76chr1028824686chr10103699695541HLA-A74:01RVRERDGVLR0.99130.5364616
WAC-C10orf76chr1028824686chr10103699695541HLA-B48:05RVRERDGVLRL0.9980.6318617
WAC-C10orf76chr1028824686chr10103699695541HLA-A30:01RVRERDGVLRL0.99780.9445617
WAC-C10orf76chr1028824686chr10103699695541HLA-B41:03RVRERDGVLRL0.5670.6788617
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:49RVRERDGVLRL0.43380.5832617
WAC-C10orf76chr1028824686chr10103699695541HLA-B40:12RVRERDGVLRL0.3380.6012617

Top

Potential FusionNeoAntigen Information of WAC-C10orf76 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WAC-C10orf76_28824686_103699695.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WAC-C10orf76chr1028824686chr10103699695541DRB1-0401RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0403RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0403DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0403ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0403RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0407DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0407RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0413RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0413DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0413ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0413RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0415RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0415ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0415RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0415DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0419RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0419DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0422DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0427RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0427DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0427ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0427RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0431RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0433RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0435RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0435DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0436RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0436ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0436RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0436DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0437RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0437DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0437ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0438RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0438DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0439RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0439DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0439ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0439RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0440RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0440ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0440DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0440RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0441RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0441DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0441ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0441RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0442RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0442DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0442ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0442RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0443RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0444RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0444DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0444ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0444RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0446RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0446DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0446ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0446RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0447RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0449RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0449DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0449ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0449RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0450RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0450DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0450ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0450RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0451RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0451DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0451ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0451RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0452RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0452DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0452ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0452RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0453RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0453ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0453DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0453RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0454RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0455RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0455DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0455ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0455RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0456RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0456ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0456DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0456RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0458RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0458ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0458DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0458RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0459RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0459DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0459ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0459RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0460RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0460DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0460ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0460RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0461RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0461DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0463RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0465RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0465DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0465ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0468RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0468ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0468DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0468RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0470RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0470ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0470DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0470RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0471RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0471DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0471ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0471RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0473RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0473DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0473ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0473RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0474DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0474RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0475RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0475DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0476RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0478DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0478RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0478ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0479RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0479DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0479ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0479RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0485RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0485DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0485ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-0485RERDGVLRLSTNAGQ823
WAC-C10orf76chr1028824686chr10103699695541DRB1-0488RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-0488DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-0488ERDGVLRLSTNAGQW924
WAC-C10orf76chr1028824686chr10103699695541DRB1-1002RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-1410DGVLRLSTNAGQWKE1126
WAC-C10orf76chr1028824686chr10103699695541DRB1-1410RDGVLRLSTNAGQWK1025
WAC-C10orf76chr1028824686chr10103699695541DRB1-1457RDGVLRLSTNAGQWK1025

Top

Fusion breakpoint peptide structures of WAC-C10orf76

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8328RVRERDGVLRLSTNWACC10orf76chr1028824686chr10103699695541

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of WAC-C10orf76

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8328RVRERDGVLRLSTN-8.62545-8.73885
HLA-B14:023BVN8328RVRERDGVLRLSTN-3.26321-4.29851
HLA-B52:013W398328RVRERDGVLRLSTN-6.23413-6.34753
HLA-B52:013W398328RVRERDGVLRLSTN-4.55402-5.58932
HLA-A24:025HGA8328RVRERDGVLRLSTN-8.62578-8.73918
HLA-A24:025HGA8328RVRERDGVLRLSTN-6.438-7.4733
HLA-B44:053DX88328RVRERDGVLRLSTN-5.68484-5.79824
HLA-B44:053DX88328RVRERDGVLRLSTN-3.64855-4.68385
HLA-A02:016TDR8328RVRERDGVLRLSTN-5.14764-6.18294

Top

Vaccine Design for the FusionNeoAntigens of WAC-C10orf76

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
WAC-C10orf76chr1028824686chr10103699695615RVRERDGVLGAGTTAGAGAGAGGGATGGTGTCCTGA
WAC-C10orf76chr1028824686chr10103699695616RVRERDGVLRGAGTTAGAGAGAGGGATGGTGTCCTGAGGC
WAC-C10orf76chr1028824686chr10103699695617RVRERDGVLRLGAGTTAGAGAGAGGGATGGTGTCCTGAGGCTTT
WAC-C10orf76chr1028824686chr10103699695717VRERDGVLRLTTAGAGAGAGGGATGGTGTCCTGAGGCTTT
WAC-C10orf76chr1028824686chr10103699695817RERDGVLRLGAGAGAGGGATGGTGTCCTGAGGCTTT
WAC-C10orf76chr1028824686chr10103699695917ERDGVLRLAGAGGGATGGTGTCCTGAGGCTTT
WAC-C10orf76chr1028824686chr10103699695918ERDGVLRLSAGAGGGATGGTGTCCTGAGGCTTTCTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
WAC-C10orf76chr1028824686chr101036996951025RDGVLRLSTNAGQWKGGGATGGTGTCCTGAGGCTTTCTACCAATGCAGGCCAGTGGAAGG
WAC-C10orf76chr1028824686chr101036996951126DGVLRLSTNAGQWKEATGGTGTCCTGAGGCTTTCTACCAATGCAGGCCAGTGGAAGGAAG
WAC-C10orf76chr1028824686chr10103699695823RERDGVLRLSTNAGQGAGAGAGGGATGGTGTCCTGAGGCTTTCTACCAATGCAGGCCAGT
WAC-C10orf76chr1028824686chr10103699695924ERDGVLRLSTNAGQWAGAGGGATGGTGTCCTGAGGCTTTCTACCAATGCAGGCCAGTGGA

Top

Information of the samples that have these potential fusion neoantigens of WAC-C10orf76

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
READWAC-C10orf76chr1028824686ENST00000347934chr10103699695ENST00000370033TCGA-AG-3887

Top

Potential target of CAR-T therapy development for WAC-C10orf76

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to WAC-C10orf76

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to WAC-C10orf76

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource